Contact Lens Spectrum

References

December 2019

Document #289

(p. 13) Prescribing for Presbyopia – Orthokeratology for Presbyopia
By Matthew Lampa, OD

  1. Walline JJ. Myopia Control: A Review. Eye Contact Lens. 2016 Jan;42:3-8.

(p. 14) GP Insights – Blepharoptosis and GPs: Are We Doing Harm?
By Roxanna T. Potter, OD

  1. Hwang K, Kim JH. The Risk of Blepharoptosis in Contact Lens Wearers. J Craniofac Surg. 2015 Jul;26:e373-e374.
  2. Kitazawa T. Hard contact lens wear and the risk of acquired blepharoptosis: a case-control study. Eplasty. 2013 Jun 19;13:e30.
  3. Bleyen I, Hiemstra CA, Devongelaere T, van den Bosch WA, Wubbels RJ, Paridaens DA. Not only hard contact lens wear but also soft contact lens wear may be associated with blepharoptosis. Can J Ophthalmol. 2011 Aug;46:333-336.
  4. Burmann TG, Valiatti FB, Obalski L, Marcon I. [Blepharoptosis in contact lens wearers]. Arq Bras Oftalmol. 2006 Sep-Oct;69:651-653.
  5. Thean JH, McNab AA. Blepharoptosis in RGP and PMMA hard contact lens wearers. Clin Exp Optom. 2004 Jan;87:11-14.
  6. Watanabe A, Araki B, Noso K, Kakizaki H, Kinoshita S. Histopathology of blepharoptosis induced by prolonged hard contact lens wear. Am J Ophthalmol. 2006 Jun;141:1092-1096.
  7. Yang B, Liu L, Cho P. Does Long-Term Rigid Contact Lens Wear Lead to Acquired Blepharoptosis in Chinese Eyes? Eye Contact Lens. 2019 Apr 9.
  8. Shah-Desai SD, Aslam SA, Pullum K, Beaconsfield M, Rose GE. Scleral contact lens usage in patients with complex blepharoptosis. Ophthalmic Plast Reconstr Surg. 2011 Mar-Apr;27:95-98.
  9. Katsoulos K, Rallatos GL, Mavrikakis I. Scleral contact lenses for the management of complicated ptosis. Orbit. 2018 Jun;37:201-207.

(p. 15) Dry Eye Dx and Tx – Depression and Dry Eye
By Katherine M. Mastrota, MS, OD

  1. Weatherby TJM, Raman VRV, Agius M. Depression and dry eye disease: a need for an interdisciplinary approach? Psychiatr Danub. 2019 Sep;31:619-621.
  2. Lakkis NA, Mahmassani DM. Screening instruments for depression in primary care: a concise review for clinicians. Postgrad Med. 2015 Jan;127:99-106.

(p. 46) Orthokeratology Today – Prescribe Like They Are Your Kids
By Michael J. Lipson, OD

  1. Wolffsohn JS, Calossi A, Cho P, et al. Global trends in myopia management attitudes and strategies in clinical practice. Cont Lens Ant Eye. 2016 Apr;39:106-116.
  2. Lipson MJ, Sugar A, Musch DC. Overnight corneal reshaping versus soft disposable contact lenses: vision-related quality-of-life differences from a randomized clinical trial. Optom Vis Sci. 2005 Oct;82:882-891.
  3. Lipson MJ. Long-term clinical outcomes for overnight corneal reshaping in children and adults. Eye Contact Lens. 2008 Mar;34:94-99.
  4. Liu YM, Xie P. The Safety of Orthokeratology—A Systematic Review. Eye Contact Lens. 2016 Jan;42:35-42.
  5. Bullimore MA, Sinnott LT, Jones-Jordan LA. The risk of microbial keratitis with overnight corneal reshaping lenses. Optom Vis Sci. 2013 Sep;90:937-944.

(p. 48) Pediatric and Teen CL Care – Atropine and Lenses for Myopia Management
By Melanie Frogozo, OD

  1. Holden BA, Fricke DA, Wilson M, et al. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology. 2016 May;123:1036-1042.
  2. Wu PC, Huang HM, Yu HJ, Fang PC, Chen CT. Epidemiology of Myopia. Asia Pac J Ophthalmol (Phila). 2016 Nov/Dec;5:386-393.
  3. Cho BJ, Shin JY, Yu HG. Complications of Pathologic Myopia. Eye Contact Lens. 2016 Jan;42:9-15.
  4. Walline J J. Myopia Control: A Review. Eye Contact Lens. 2016 Jan;42:3-8.
  5. McBrien NA, Stell WK, Carr B. How does atropine exert its anti-myopia effects? Ophthalmic Physiol Opt. 2013 May;33:373-378.
  6. Chia A, Chua WH, Cheung YB, et al. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2). Ophthalmology. 2012 Feb;119:347-354.
  7. Yam JC, Jiang Y, Tang SM,et al. Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control. Ophthalmology. 2019 Jan;126:113-124.
  8. Huang J, Mutti DO, Jones-Jordan LA, Walline JJ. Bifocal & Atropine in Myopia Study: Baseline Data and Methods. Optom Vis Sci. 2019 May;96:335-344.
  9. Tan Q, Ng AL, Cheng GP, Woo VC, Cho P. Combined Atropine with Orthokeratology for Myopia Control: Study Design and Preliminary Results. Curr Eye Res. 2019 Jun;44:671-678.